Shopping Cart
- Remove All
- Your shopping cart is currently empty
AM-1638 is a full agonist of GPR40/FFA1 (EC50: 0.16 μM).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | 848 € | 8-10 weeks | |
50 mg | 1.102 € | 8-10 weeks | |
100 mg | 1.653 € | 8-10 weeks |
Description | AM-1638 is a full agonist of GPR40/FFA1 (EC50: 0.16 μM). |
Targets&IC50 | FFA1/GPR40:0.16 μM |
In vivo | AM-1638 demonstrates moderate cross-species plasma clearance and distribution volume, leading to plasma half-lives conducive to the assessment of its antidiabetic effects in mice, rats, and cynomolgus monkeys. It shows antidiabetic activity in BDF/DIO mice[1]. Furthermore, the oral administration of the full agonist AM-1638 reveals superb oral bioavailability, exceeding 100% in mice, and achieving 72% and 71% in rats and cynomolgus monkeys, respectively. |
Molecular Weight | 514.63 |
Formula | C33H35FO4 |
Cas No. | 1142214-62-7 |
Relative Density. | 1.193 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 250 mg/mL (485.79 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.